Policy / Pricing

Biotech leaders pitch Pazdur as next FDA chief

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

pharminent May 14, 2026 (Last updated: May 14, 2026)

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

Related Stories

EFPIA report adds to pressures on EU drug pricing policy

US launches probe of German ‘underpayment’ for medicines

FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

You May Have Missed

Lilly Medicare GLP-1 Bridge Launches July 1 With Foundayo and Zepbound

Moderna Maps R&D ‘Horizons’ as 2028 Break-Even Goal Looms

Replimune gets early August decision date for twice-rejected melanoma drug

Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms